{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:54:39Z","timestamp":1773788079054,"version":"3.50.1"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1365-2133.2008.08874.x","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T09:40:09Z","timestamp":1229420409000},"page":"1-7","source":"Crossref","is-referenced-by-count":45,"title":["Psoriasis: an opportunity to identify cardiovascular risk"],"prefix":"10.1093","volume":"160","author":[{"given":"D.G.","family":"Federman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Shelling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Prodanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"Kirsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB1","unstructured":"1National Psoriasis Foundation. Psoriasis Statistics. Available at: http:\/\/www.psoriasis.org\/about\/stats (last accessed 4 June 2008)."},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB3","first-page":"280","article-title":"The impact of psoriasis on quality of life. Results of a 1998 National Psoriasis Foundation patient-membership survey","volume":"137","author":"Krueger","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/135910539700200409","article-title":"The physical, psychological, and social impact of psoriasis","volume":"2","author":"Rapp","year":"1997","journal-title":"J Health Psychol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB5","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Schon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis. Results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"issue":"1 Suppl. 1","key":"10.1111\/j.1365-2133.2008.08874.x-BIB9","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis - recent advances in understanding its pathogenesis and treatment","volume":"53","author":"Krueger","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1440-0960.2006.00262.x","article-title":"Immunopathogenesis of psoriasis","volume":"47","author":"Lee","year":"2006","journal-title":"Aust J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2008.08874.x-BIB11","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaad.2007.07.016","article-title":"Interleukin-12, interleukin-23, and psoriasis: current prospects","volume":"57","author":"Torti","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.178.1.592","article-title":"An inflammatory pathway of IFN-gamma production in coronary atherosclerosis","volume":"178","author":"Ranjbaran","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB15","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.autrev.2005.08.008","article-title":"Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms","volume":"5","author":"Rhew","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jaad.2006.09.017","article-title":"The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study","volume":"56","author":"Shapiro","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1468-3083.2006.01773.x","article-title":"Comorbidities in psoriasis","volume":"20","author":"Christophers","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Mallbris","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0009-8981(00)00358-2","article-title":"Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease","volume":"303","author":"Rocha-Pereira","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amjmed.2007.06.020","article-title":"Smoking and the risk of psoriasis in women: Nurses\u2019 Health Study II","volume":"120","author":"Setty","year":"2007","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/archderm.141.12.1580","article-title":"Relationship between smoking and the clinical severity of psoriasis","volume":"141","author":"Fortes","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB26","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/archderm.143.12.1559","article-title":"Incidence and risk factors for psoriasis in the general population","volume":"143","author":"Huerta","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB27","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999-2004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","article-title":"Overweight and obesity in the United States: prevalence and trends 1960-1994","volume":"22","author":"Flegal","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa055643","article-title":"Overweight, obesity, and mortality in a large cohort of persons 50-71\u2003years old","volume":"355","author":"Adams","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.suc.2005.04.006","article-title":"Health ramifications of the obesity epidemic","volume":"85","author":"Li","year":"2005","journal-title":"Surg Clin North Am"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB32","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMra012586","article-title":"Obesity","volume":"346","author":"Yanovski","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2008.08874.x-BIB34","first-page":"615S","article-title":"Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference Statement","volume":"55","author":"Consensus Panel","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB36","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB37","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB38","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200001030-00003","article-title":"Drug-induced psoriasis. Recognition and management","volume":"1","author":"Tsankov","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0190-9622(88)70242-X","article-title":"Beta-blocking drugs and psoriasis. A review of cutaneous side effects and retrospective analysis of their effects on psoriasis","volume":"19","author":"Gold","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/000331970205300617","article-title":"Beta-blocker-induced psoriasis: a rare side effect - a case report","volume":"53","author":"Yilmaz","year":"2002","journal-title":"Angiology"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000106419","article-title":"Environmental factors and psoriasis","volume":"35","author":"Dika","year":"2007","journal-title":"Curr Probl Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/00015550510032823","article-title":"Drug exposure and psoriasis vulgaris: case-control and case-crossover studies","volume":"85","author":"Cohen","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB44","first-page":"162","article-title":"Psoriasiform eruption induced by captopril and chlorthalidone","volume":"40","author":"Wolf","year":"1987","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1540-9740.2006.04515.x","article-title":"Psoriatic erythroderma associated with enalapril","volume":"5","author":"Antonov","year":"2006","journal-title":"Skinmed"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB46","first-page":"406","article-title":"Candesartan cilextil induced pustular psoriasis","volume":"13","author":"Kawamura","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2133.2002.48848.x","article-title":"Sartans, angiotensin II receptor antagonists, can induce psoriasis","volume":"147","author":"Marquart-Elbaz","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB48","first-page":"978","article-title":"The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial","volume":"329","author":"Diabetes Control and Complications Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB49","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199307293290502","article-title":"The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus","volume":"329","author":"Reichard","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB50","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB51","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB52","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Diabetes Control and Complications Group\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB53","first-page":"6","article-title":"The ACCORD trial: a multidisciplinary approach to control cardiovascular risk in type 2 diabetes mellitus","volume":"23","author":"Bastien","year":"2004","journal-title":"Pract Diabetol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB54","first-page":"225","article-title":"Women with palmopustular psoriasis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study","volume":"85","author":"Hagforsen","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00561533","article-title":"Statistical association between psoriasis and diabetes: further results","volume":"254","author":"Binazzi","year":"1975","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB56","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB57","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2337\/dc06-9912","article-title":"Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"29","author":"Nathan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB58","first-page":"869","article-title":"Cigarette smoking among adults - United States, 1999","volume":"50","author":"Centers for Disease Contol and Prevention (CDC)","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB59","first-page":"986","article-title":"Tobacco use - United States, 1990-1999","volume":"48","author":"Centers for Disease Contol and Prevention (CDC)","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB60","volume-title":"The Health Benefits of Smoking Cessation: A Report of the Surgeon General","author":"Department of Health and Human Services","year":"1990"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB61","volume-title":"Treating Tobacco Use and Dependence","author":"Fiore","year":"2000"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJMcp012279","article-title":"Treatment of tobacco use and dependence","volume":"346","author":"Rigotti","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB63","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1517\/14656566.8.11.1757","article-title":"Varenicline: progress in smoking cessation treatment","volume":"8","author":"Glover","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB64","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7\u2003week, randomized, placebo- and buproprion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB65","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ajp.2007.07010173","article-title":"Varenicline-induced manic episode in a patient with bipolar disorder","volume":"164","author":"Kohen","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB66","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ajp.2007.07020326","article-title":"Exacerbation of schizophrenia by varenicline","volume":"164","author":"Freedman","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.281.1.72","article-title":"Recent advances in the pharmacotherapy of smoking","volume":"281","author":"Hughes","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/bmj.303.6797.276","article-title":"Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations","volume":"303","author":"Chen","year":"1991","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB69","first-page":"1267","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"356","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB70","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Panel III Guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB72","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of coronary heart disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB73","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0002-9343(86)90289-5","article-title":"Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time and thromboxane A2 levels in bleeding-time blood","volume":"81","author":"Stampfer","year":"1986","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trial of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB75","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomized trial of low-intensity oral anticoagulation and low-dose aspirin in the prevention of ischaemic heart disease in men at increased risk","volume":"351","author":"The Medical Research Council\u2019s General Practice Research Framework","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB77","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood pressure-lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice","volume":"357","author":"Collaborative Group of the Primary Prevention Project","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","volume":"136","author":"Preventive Services Task Force","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB80","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation","volume":"286","author":"D\u2019Agostino","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB81","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB82","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMcp012672","article-title":"Aspirin for primary prevention for coronary events","volume":"346","author":"Lauer","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08874.x-BIB83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08874.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08874.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:55:25Z","timestamp":1738821325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/1\/1\/6641657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08874.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}